Journal de Pharmacie Clinique
Knowledge sharing: the key to development
The Journal de Pharmacie Clinique is a journal with a clear objective: to share and disseminate knowledge.
Its content is structured in 5 main themes allowing to be informed about the latest advances concerning the pharmaceutical missions of the pharmacist:
- Pharmacotechnics l Production l Logistics
- Pharmaceutical care
- Teaching l Training
- Management l Organization
The editorial content of the journal will offer you, in the course of the issues, synthesis articles, original articles, congress feedbacks...
Journal de Pharmacie Clinique is also open to pharmaceutical and clinical practices in French-speaking and European countries.
Here you will find all John Libbey Eurotext (JLE) policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.
- Editorial policy
- Peer review policy
- Commercial policy
- Ethical rules - Links of interest, human and animal rights, informed patient consent
- Corrections, retractions and expressions of reservations
- Copyright, Open Access and data sharing
INSTRUCTIONS TO AUTHORS
Journal de Pharmacie Clinique is a journal for pharmacists whose vocation is to encourage, stimulate and promote the sharing of information and knowledge between health professionals at the local, national or international level. This quarterly international peer-reviewed journal is the communication arm of the Européenne de Formation pour les Pharmaciens (European Training Center for Pharmacists - EFP), a law 1901 association. The international quality of the journal requires that the proposed articles comply with the proposed international standards by the Vancouver group  for the presentation of the manuscripts, the originality of the data presented and the information provided to the readers of the journal.
Authors are encouraged to read the following instructions and recommendations carefully. Any non-compliant manuscript will be returned to the authors without analysis by the editorial board of the journal.
Your manuscript is to be submitted on the online submission platform at: https://jpc.manuscriptmanager.net
It is possible to submit manuscripts relating to the five major areas corresponding to the processes of pharmaceutical missions, namely:
- Pharmaceutical care,
- Education and training,
All research relating to human participants must be conducted in accordance with the principles of the Helsinki Declaration. Authors should indicate whether the research was carried out in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and the Helsinki Declaration (www.wma.net/en/30publications/10policies/b3/index.html).
They take stock of a "topical" issue. Often commissioned by the editorial board of the journal, spontaneous submissions are also welcome. The text must not exceed 2500 words and 10 references.
They report original research results. They include a structured summary (in French and English) (max 200 words), 1) Introduction (current state of the problem and objective (s) of work), 2) Methods, 3) Results, 4) Conclusion. The text must not exceed 4,500 words (excluding title, abstract, names of authors, affiliations, references, tables and figures) and must not contain more than 40 references and 8 illustrations (tables and / or figures).
REVIEWS / FOCUS
They are intended to present a knowledge update and highlight recent acquisitions of data on a specific and well-defined subject. They include a structured summary (in French and English) (max 200 words), 1) Context, 2) Objective, 3) Documentary sources (key words and language), 4 Selection of studies, 5) Results, 6) Conclusion. The text must not exceed 4,500 words (excluding title, abstract, names of authors, affiliations, references, tables and figures) and must not contain more than 60 references (current and selective) and 8 illustrations (tables and / or figures) .
Their purpose is to present research results in a brief form. They include a structured summary (in French and English) (max 150 words), 1) Introduction (current state of the problem and objective (s) of the work), 2) Methods, 3) Results, 4) Conclusion. The text must not exceed 2,500 words (excluding title, abstract, names of authors, affiliations references, tables and figures) and must not contain more than 30 references and 4 illustrations (tables and / or figures).
OTHER EDITORIAL FORMS
Clinical cases and review of articles sections must include an unstructured abstract (in French and English) (max 150 words). The text should not exceed 2,000 words and 15 references. The section "letters to the editor" only concerns reactions to articles previously published in the Journal de Pharmacie Clinique. The text must not exceed 700 words and 5 references.
INSTRUCTIONS COMMON TO ALL THE SECTIONS
Manuscripts are written in French or English. In both cases, the grammatical and orthographic rules must be rigorously respected: the editorial committee will return, before their expertise, all the manuscripts if they are written in incorrect or insufficient French or English. Texts must be typewritten (Word, compatible PC software) in double spacing, in Times New Roman 12 font (justification of the text on the left and on the right).
Submissions will include the following:
A SUBMISSION DECLARATION including the following:
- A mention that the manuscript is original, is not considered by another journal, has not already been published, and has been approved by all authors.
- A mention that all authors fulfill the conditions of authors. ICMJE's international criteria allow paternity of articles to be defined (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
A contributor can only be considered an author if it meets at least these 4 criteria (as defined by the ICMJE):
- Have contributed substantially to the design of the study; or the acquisition, analysis or interpretation of the data; AND
- Have participated in writing the article or critically reviewing its intellectual content; AND
- Have approved the final version to be published; AND
- Agree with all aspects of the work by ensuring that issues related to the accuracy or integrity of the overall work are duly considered and resolved.
The lead author is the one who has made a substantial contribution to the design and writing of the manuscript.
- A mention that the authors obtained written agreement of the individuals named in the acknowledgments to mention their names. "I certify that all persons named in the acknowledgments have given written authorization to be named". "I certify that all persons who have made a significant contribution to the manuscript (eg, data collection, analysis, writing), but who do not meet the nominated paternity criteria are named in the acknowledgments section".
- A statement describing work-related financial supports and conflicts of interest.
- A mention relating to the transfer of copyrights; involving after publication a written authorization from the Journal de Pharmacie Clinique to reproduce the text, figures, tables and illustrations. "By submitting this manuscript, I agree to transfer the copyrights to the Journal of Clinical Pharmacy"
A TITLE PAGE including:
- A title: in French and in English. It must be informative and explicit.
- A short title: in French and English, limited to 80 characters (spaces included).
- The names, surnames and affiliations of the authors.
- Full details of the corresponding author (establishment and service of attachment, postal address, email address, telephone number).
A SUMMARY PAGE including:
- A summary (in French and in English)
- Three to five key words (in French and in English)
- The title
- The text
- Conflicts of interest : See Conflicts of Interest section.
- Acknowledgments. Refer to Acknowledgments section.
- The references. The bibliographic references will be classified in their order of appearance in the text. They are called in the text by their number in brackets, the numbers are separated by commas when it comes to two consecutive digits or not, and by hyphens when it comes to at least three digits consecutive - only extreme numbers are then cited: [5, 7], [9-11], [5, 7, 9-11, 13]. The brackets are placed at the end of the sentence before the point. Indicate all authors if they are 3 or less, or the first 3 authors followed by the mention "et al.” When they are more numerous. They will be written in accordance with the standards of the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals, Fifth Edition, N Engl J Med 1997, 336: 309-16. All references must be cited in the text.
Classic periodical article
Name of the authors followed by the initials of their first names. Title of the article in the original language. Name of the abridged journal according to the type of the Index medicus (no punctuation after the abbreviations); year, volume: first and last pages of the article.
Skalli S, Nouvel M, Faudel A, Fougère S, et al. La transplantation rénale et les immunosuppresseurs : place du pharmacien clinicien dans la prise en charge thérapeutique. J Pharm Clin. 2013;32:201-18.
Article in press: indicate the DOI (digital object identifier) of the article
Cotrina-Luque J, Gil-Navarro MV, Acosta-García H, et al. Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa. Int J Clin Pharm. 2015;DOI 10.1007/s11096-015-0208-y
Article from a supplement to a volume
Bergert FW, Braun M, Ehrenthal K, et al. Recommendations for treating adult and geriatric patients on multimedication. Int J Clin Pharmacol Ther. 2014;52 (Suppl 1):S1-S64.
Authors’ names. Title of the book. City : publisher, year of publication.
Garnier JP, Le Moël G, Beaudeux JL. Actualités en Pharmacie et Biologie cliniques. Maladie d'Alzheimer. AVC. Protéomique, métabolomique. Paris: John Libbey Eurotext; 2009.
Authors’ names. Title of the chapter in the original language. In: names of the editors with their first name’s initial letter. Title of the book. City : publisher, year of publication : first and last pages of the chapter.
Ectors N. Anatomopathologie du cancer gastrique. In: Mégraud F, Lamouliatte H, éd. Helicobacter pylori. Vol. 2. Paris: Elsevier; 1997. p. 221-41.
EAHP Survey 2010. Brussels (Belgium): European Association of Hospital Pharmacists; 2016 [cited 2016 Feb 03]. Available from: http://www.eahp.eu/publications/survey/eahps-2010-survey-hospital-pharmacy-practice-europe
The tables are presented on separate pages at the end of the manuscript (one table per page). The tables must be entered in 1.5 line spacing and include their number, a title and possibly explanatory notes. They will be numbered in Arabic numerals and called in the text by their number. They must be included after the references (one page per table).
The illustrations are submitted separately. The illustrations (diagrams, figures, photographs) will be numbered in Arabic numerals and indexed in the text by recall of their number. Lettering (symbols, numbers, etc.) must be uniform for all figures and of sufficient size to remain legible after reduction. They must allow their reading and their understanding without need to refer to the text. The photographic documents must be of excellent quality (or definition of 600 dpi minimum for the computer versions in the format jpeg or tiff). All artwork documents must be referred to in the text. In the event that some of the illustrations are made by third parties, whether they have already been published or not, the authors undertake to provide with the manuscript all the authorizations necessary for their inclusion in their article. They will communicate these authorizations of reproduction with his manuscript. These permissions are generally granted via the https://www.copyright.com website (see "Get permission" button available for each article).
They are to be avoided. Any acronym or abbreviation needed must be made explicit when first appearing in the text.
SIZES AND UNITS
Units of the International System of Units (SI) shall be used.
CONFLICTS OF INTERESTS
The authors are all committed to inform the editorial staff of the Journal de Pharmacie Clinique about their possible conflicts of interests. A declaration of interests will be sent to them together with the first proofs, where they will be asked to mention the financial interests, clinical trials, punctual interventions or family relations likely to influence their professional judgments.
Acknowledgments highlight contributions that do not warrant a place among the authors. Authors must obtain the written consent of the individuals named in the acknowledgments to mention their names.
EVALUATION OF ARTICLES
Manuscripts are submitted to the Editorial Board which entrusts them to at least two experts of the specialty for opinion. Articles must not have been pre-published. Articles may be accepted with minor, major or rejected edits.
They become, after acceptance, the property of the publisher and cannot be reproduced (in part or in whole) without its prior authorization. For more information on the international requirements for submitting manuscripts to biomedical journals, visit the International Committee of Medical Journal Editors (ICMJE) at www.icmje.org. For more information on the responsibilities and rights of biomedical journal publishers, visit this page of the Council of Science editors (CSE) website at: http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3286
Only original articles, journals, brief papers and clinical cases are reprinted in the form of a PDF file sent to the corresponding author.
 International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Version updated in December 2017. http://www.icmje.org/icmje-recommendations.pdf